Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/28759
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fogarty, Tamara | - |
dc.contributor.author | Tacey, Mark A | - |
dc.contributor.author | McCorkell, Giulia | - |
dc.contributor.author | Kok, David | - |
dc.contributor.author | Hornby, Colin | - |
dc.contributor.author | Milne, Roger L | - |
dc.contributor.author | Millar, Jeremy | - |
dc.contributor.author | Foroudi, Farshad | - |
dc.contributor.author | Ong, Wee Loon | - |
dc.date | 2022-02-01 | - |
dc.date.accessioned | 2022-02-11T03:19:45Z | - |
dc.date.available | 2022-02-11T03:19:45Z | - |
dc.date.issued | 2022-08 | - |
dc.identifier.citation | Journal of Medical Imaging and Radiation Oncology 2022; 66(5): 678-687 | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/28759 | - |
dc.description.abstract | To describe the pattern of the use of advanced radiation therapy (RT) techniques, including intensity-modulated RT (IMRT), volumetric modulated arc therapy (VMAT), and stereotactic body RT (SBRT) for the management of bone metastases (BM), and the associated factors in Victoria. We used a population-based cohort of patients from the state-wide Victorian Radiotherapy Minimum Data Set (VRMDS) who received RT for BM between 2012 and 2017. The primary outcome was proportion of RT courses using advanced RT techniques. The Cochran-Armitage test for trend was used to evaluate temporal trend in advanced RT use. Multinomial logistic regression was used to identify factors associated with advanced RT use. A total of 18,158 courses of RT were delivered to 10,956 patients-16,626 (91.6%) courses were 3D conformal RT, 857 (4.7%) IMRT/VMAT and 675 (3.7%) SBRT. There was a sharp increase in IMRT/VMAT use from <1% in 2012-2015, to 10.1% in 2016 and 16.3% in 2017 (P-trend < 0.001). Increase in SBRT use was more gradual, from 1.2% in 2012 to 4.8% in 2016 and 5.5% in 2017 for SBRT (P-trend<0.001). In multivariate analyses, year of RT was the strongest predictor of IMRT/VMAT use (OR = 41; 95%CI = 25-67; P < 0.001, comparing 2012-2013 and 2016-2017). Primary tumour type (prostate cancer) was the strongest predictor of SBRT use (OR = 6.07; 95% CI = 4.19-8.80; P < 0.001). Overall, there was increasing trend in the use of advanced RT techniques for BM in Victoria, with a distinct pattern for IMRT/VMAT compared with SBRT - SBRT uptake was more gradual while IMRT/VMAT uptake was abrupt, occurring contemporaneously with Medicare Benefit Scheme funding changes in 2016. | en |
dc.language.iso | eng | - |
dc.subject | IMRT | en |
dc.subject | VMAT | en |
dc.subject | bone metastases | en |
dc.subject | radiation therapy | en |
dc.subject | stereotactic | en |
dc.title | Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Journal of Medical Imaging and Radiation Oncology | en |
dc.identifier.affiliation | Olivia Newton-John Cancer Wellness and Research Centre | en |
dc.identifier.affiliation | Department of Epidemiology and Preventive Medicine, Monash University, Prahran, Victoria, Australia | en |
dc.identifier.affiliation | Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia | en |
dc.identifier.affiliation | Central Clinical School, Monash University, Prahran, Victoria, Australia | en |
dc.identifier.affiliation | Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | School of Clinical Medicine, University of Cambridge, Cambridge, UK | en |
dc.identifier.affiliation | Victorian Department of Health, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Department of Radiation Oncology, Alfred Health, Melbourne, Victoria, Australia | en |
dc.identifier.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/35106919/ | en |
dc.identifier.doi | 10.1111/1754-9485.13381 | en |
dc.type.content | Text | en |
dc.identifier.orcid | 0000-0002-3383-4656 | en |
dc.identifier.orcid | 0000-0001-8387-0965 | en |
dc.identifier.orcid | 0000-0001-6657-7193 | en |
dc.identifier.orcid | 0000-0003-2948-8495 | en |
dc.identifier.pubmedid | 35106919 | - |
local.name.researcher | Foroudi, Farshad | |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.fulltext | No Fulltext | - |
crisitem.author.dept | Radiation Oncology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
crisitem.author.dept | Radiation Oncology | - |
crisitem.author.dept | Radiation Oncology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.